Cargando…
Differences in right ventricular function and response to targeted therapy between patients with IPAH and PAH-CHD
Background and aims: Pulmonary arterial hypertension (PAH) is a chronic pulmonary vascular disorder characterized by elevated pulmonary vascular resistance (PVR) and pulmonary arterial pressure (PAP). Right heart failure is a life-threatening complication of PAH and predicts a poor prognosis. PAH as...
Autores principales: | Zhu, Tengteng, Wu, Panyun, Tan, Zhen, Jin, Quan, Chen, Yusi, Li, Lian, Chen, Zewei, Tang, Yirui, Li, Jiang, Fang, Zhenfei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968930/ https://www.ncbi.nlm.nih.gov/pubmed/36860300 http://dx.doi.org/10.3389/fphar.2023.1124746 |
Ejemplares similares
-
Evaluating the role of serum uric acid in the risk stratification and therapeutic response of patients with pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD)
por: Luo, Jun, et al.
Publicado: (2023) -
Local and Systemic RAGE Axis Changes in Pulmonary Hypertension: CTEPH and iPAH
por: Moser, Bernhard, et al.
Publicado: (2014) -
Role of Gut Microbiota in Pulmonary Arterial Hypertension
por: Wu, Panyun, et al.
Publicado: (2022) -
Current understanding of the contribution of lactate to the cardiovascular system and its therapeutic relevance
por: Wu, Panyun, et al.
Publicado: (2023) -
Protective effect of HTK solution on postoperative pulmonary function in infants with CHD and PAH
por: Li, Jindong, et al.
Publicado: (2017)